Fragoulis, George E;
Nikiphorou, Elena;
Dey, Mrinalini;
Zhao, Sizheng Steven;
Courvoisier, Delphine Sophie;
Arnaud, Laurent;
Atzeni, Fabiola;
Behrens, Georg M. N;
Bijlsma, Johannes W. J;
Böhm, Peter;
Constantinou, Costas A;
Garcia-Diaz, Silvia;
Kapetanovic, Meliha Crnkic;
Lauper, Kim;
Luís, Mariana;
Morel, Jacques;
Nagy, György;
Polverino, Eva;
van Rompay, Jef;
Sebastiani, Marco;
Strangfeld, Anja;
Thurah, Annette de;
Galloway, James;
Hyrich, Kimme L.
To develop EULAR recommendations for
screening and prophylaxis of chronic and opportunistic
infections in patients with autoimmune inflammatory
rheumatic diseases (AIIRD).
An international Task Force (TF) (22
members/15 countries) formulated recommendations,
supported by systematic literature review find...
Prévention des Maladies,
Infections opportunistes/étiologie,
Maladies auto-immunes/complications,
Rhumatismes/complications,
Triage/normes,
Tuberculose/prévention et contrôle,
Hépatite B/prévention et contrôle,
Hépatite C/prévention et contrôle,
Herpèsvirus humain de type 3,
Pneumocystis carinii/immunologie,
Prophylaxie après exposition,
Antiviraux/usage thérapeutique
About one fourth of the world’s population is estimated to be infected with the tuberculosis (TB) bacterium, and about 5–10% of those infected develop active TB disease in their lifetime. The risk for active TB disease after infection depends on several factors, the most important being the person’...
This guideline covers preventing, identifying and managing latent and active tuberculosis (TB) in children, young people and adults. It aims to improve ways of finding people who have TB in the community and recommends that everyone under 65 with latent TB should be treated. It describes how TB services ...
Infection prevention and control consists of evidence-based measures intended to prevent exposure and reduce the risk of transmission of infectious agents.
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessme...
Isoniazid (H) is one of the most important first-line medicines for the treatment of active
tuberculosis (TB) and latent TB infection (LTBI), with high bactericidal activity and a good safety profile. The emergence of TB strains resistant to isoniazid threaten to reduce the effectiveness of TB treatment....
Early detection of tuberculosis (TB) is essential to improve health outcomes for people with TB, and to reduce TB transmission more effectively. Systematic screening in high risk groups is a complement to efforts to improve the patient-initiated pathway to TB diagnosis (that is, diagnosing TB among peopl...
This Guideline outlines the purpose and the target audience of the second edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children. It discusses the difference between TB in children and adolescents and TB in adults and provides an estimate of the burden of c...
Air travel is now widely accessible, with a resulting increase in the numbers
of international air travellers and a consequently greater risk of communicable diseases being spread by infectious travellers. The transmission of airborne infections between people in confined spaces such as aircraft cabins i...
In 2004, the World Health Organization (WHO) published an interim policy on collaborative TB/HIV activities
in response to demand from countries for immediate guidance on actions to decrease the dual burden of
tuberculosis (TB) and human immunodeficiency virus (HIV). The term interim was used because the...
Intersecting epidemics Tuberculosis (TB) remains a considerable global public health concern, mainly affecting poor and vulnerable populations. Every year, more than 9 million people fall ill with this infectious disease, and close to 2 million die from it. Diabetes, a chronic metabolic disease that is i...
